Darar Charmake, Mohammed El-Azrak, Mohammed Boutaybi, Noha El Ouafi, Zakaria Bazid
Departement of Cardiology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda/Mohammed I University, Oujda, Morocco.
Epidemiological Laboratory of Clinical Research and Public Health, Mohammed VI University Hospital, Oujda, Morocco.
Egypt Heart J. 2022 Apr 11;74(1):25. doi: 10.1186/s43044-022-00267-9.
Brugada syndrome is a rare but serious inherited heart disease that causes sudden cardiac death by polymorphic ventricular tachycardia or ventricular fibrillation. It is an autosomal dominant genetic disease that usually occurs in patients in their forties with a structurally normal heart. Electrically, it manifests by ST elevation segment ≥ 2 mm of at least one right precordial lead (V1 and/or V2). Stratification of sudden cardiac death in Brugada syndrome is not always easy and constitutes a real challenge for the practitioner. In this review, we will present the current state of knowledge for arrhythmic risk stratification and the prevention of sudden cardiac death that can result from this syndrome.
Brugada综合征是一种罕见但严重的遗传性心脏病,可通过多形性室性心动过速或心室颤动导致心源性猝死。它是一种常染色体显性遗传病,通常发生在40多岁、心脏结构正常的患者中。在心电图上,它表现为至少一个右胸前导联(V1和/或V2)的ST段抬高≥2毫米。对Brugada综合征的心源性猝死进行分层并不总是容易的,对医生来说是一项真正的挑战。在这篇综述中,我们将介绍心律失常风险分层以及预防该综合征可能导致的心源性猝死的当前知识状态。